Literature DB >> 24068403

Histological diagnosis and risk of renal vein thrombosis, and other thrombotic complications in primitive nephrotic syndrome.

M Hârza1, G Ismail, G Mitroi, Mihaela Gherghiceanu, A Preda, G Mircescu, I Sinescu.   

Abstract

BACKGROUND: The risk of thromboembolic events is increased in patients with nephrotic syndrome (NS) as compared with other medical conditions and is a severe complication associated with significant morbidity and mortality. We aimed to assess the risk of renal vein thrombosis, and other venous thromboembolic events (VTE) in a large cohort of patients with NS and to identify the disease-specific risk for VTE. PATIENTS AND METHODS: We performed a prospective observational study including consecutive adult patients with primitive NS admitted to our department. Clinical and biological data were obtained every six months during follow-up. Occurrence of VTE confirmed by imaging techniques was the primary study outcome.
RESULTS: We enrolled 191 patients (47±15 years, 53% men) with a median follow-up of 24 [IQR:12,36] months. During follow-up, 23 VTE occurred, of which 65.2% in the first six months. The disease-specific risk of VTE during the follow-up period was different across the histological groups, with the lowest risk in minimal change disease and IgA nephropathy and the highest in membranous nephropathy and membranoproliferative glomerulonephritis patients. In the subgroup of membranous, the severity of the subepithelial electron dense deposits did not correlate with the risk for VTE (p=0.5).
CONCLUSIONS: In this prospective study, the risk of VTE was higher in the first six months of follow-up in NS patients. The histological pattern seems to influence the risk of VTE in this setting.

Entities:  

Mesh:

Year:  2013        PMID: 24068403

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  8 in total

Review 1.  Venous Thromboembolism in Kidney Diseases and Genetic Predisposition.

Authors:  Tingting Wu; Liang V Tang; Yu Hu
Journal:  Kidney Dis (Basel)       Date:  2022-04-11

Review 2.  Nephrotic syndrome-induced thromboembolism in adults.

Authors:  Hasan F Al-Azzawi; Onyekachi C Obi; Javeryah Safi; Mingchen Song
Journal:  Int J Crit Illn Inj Sci       Date:  2016 Apr-Jun

3.  Inherited Risk Factors of Thromboembolic Events in Patients with Primary Nephrotic Syndrome.

Authors:  Gener Ismail; Bogdan Obrișcă; Roxana Jurubiță; Andreea Andronesi; Bogdan Sorohan; Mihai Hârza
Journal:  Medicina (Kaunas)       Date:  2020-05-19       Impact factor: 2.430

Review 4.  Prevalence of pulmonary thromboembolism in nephrotic syndrome patients: A systematic review and meta-analysis.

Authors:  Abdullah Nasser Leslom; Ziyad Mohammed Saeed Alrawiah; Ahmed Mohammed Ahmed Al-Asmari; Moneer Dhafer Ali Alqashaneen; Abdulaziz Oudah Tami Alahmari; Hamuod Oudah Bin Tami Al-Ahmari
Journal:  J Family Med Prim Care       Date:  2020-02-28

5.  A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome.

Authors:  Raymond Lin; Georgina McDonald; Todd Jolly; Aidan Batten; Bobby Chacko
Journal:  Kidney Int Rep       Date:  2019-12-12

6.  The Association of Syndecan-1, Hypercoagulable State and Thrombosis and in Patients With Nephrotic Syndrome.

Authors:  Xin Chen; Xuemei Geng; Shi Jin; Jiarui Xu; Man Guo; Daoqi Shen; Xiaoqiang Ding; Hong Liu; Xialian Xu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

7.  Splanchnic venous thrombosis in a nephrotic patient following COVID-19 infection: a case report.

Authors:  Maged H Hussein; Mohamad S Alabdaljabar; Noorah Alfagyh; Mohammad Badran; Khalid Alamiri
Journal:  BMC Nephrol       Date:  2021-12-29       Impact factor: 2.388

8.  Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy.

Authors:  Honghong Zou; Yebei Li; Gaosi Xu
Journal:  BMC Nephrol       Date:  2019-12-02       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.